Medications used in the treatment of gastrointestinal disorders
These lists of medications are not complete and while sometimes or often used, many of the medications are not licensed for use in cats and dogs.
| Medication | Dose | Comments |
| Anti-emetics (check for obstruction before using as they may mask signs) | ||
| Metoclopramide | 1-2 mg/kg/24 hr CRI or 0.2-0.5 mg/kg im, sq or po | D2 dopaminergic antagonist. Upper GI prokinetic, short half life when given orally or sq |
| Domperidone | 0.1-0.3 mg/kg im, iv q 12 hr or 1-2 mg/animal po | D2 dopaminergic antagonist Not commonly used |
| Maropitant | 0.5-1.0 mg/kg q 24 hr sq or 2 mg/ kg po q 24 hr | No known prokinetic effect. Blocks NK-1 receptors in the medullary vomiting centre |
| Chlorpromazine | 0.2-0.4 mg/kg sq q 8 hr | Alpha2 agonist. Affects CRTZ and emetic centre |
| Ondansetron | 0.5-1.0 mg/kg po q12-24 hr | Affects CRTZ, vagal afferent neurones |
| Cisapride | Dogs: As a promotility agent: 0.5 mg/kg q 8 hr For oesophagitis: 0.25 mg/kg po q 8-12 hr Cats: For chronic | Not a true anti-emetic, but promotility effect may decrease vomiting by enhancing gastric emptying and intestinal transit. Also used for reflux oesophagitis and con- stipation/megacolon (cats) No longer commercially available, must be obtained from a compounding phar- |
| constipation (e.g. megacolon): In combination with a stool softener (e.g. lactulose) 0.1-1 mg/ kg q 8-12 hr po or 5 mg per cat (total dose) po q 8-12 hr | macy or imported Contraindications: hypersensitivity, GI perforation/obstruction, haemorrhage | |
| Drugs for diarrhoea | ||
| Diphenoxylate | 0.1-0.2 mg/kg po q 8 hr | Narcotic analgesic |
| Loperamide | 0.1-0.2 mg/kg po q 8 hr | Narcotic analgesic |
| Antibiotics sometimes used for bacteria induced diarrhoea and other GI disorders | ||
| Ampicillin | 10-20 mg/kg iv q 6-8 hr, sq, po | Anaerobic infections |
| Cephalathin | 22-44 mg/kg q po 6-8 hr | Gram-negative organisms |
| Clarithromycin | 4-12 mg/kg po q 12 hr | As part of treatment for Helicobacter spp. |
| Clavulanate-po- tentiated amoxicillin | 8.75 mg/kg iv q 8 hr 8.75 mg/kg im or sc of 24 hr 12.5 mg/kg po q 8-12 hr | As part of treatment for Helicobacter spp. |
| Enrofloxacin | 3-5 mg/kg po q 12 hr | Gram-negative organisms and Boxer histiocytic colitis. Caution with use in cats due to potential blindness. |
| Erythromycin | 10 mg/kg po q 8 hr | Campylobacter only, may cause diarrhoea |
| Erythromycin | 0.1-50 mg/kg po q 8 hr | Low dose to promote fasting motility, mimics motilin in dogs |
| Gentamicin | 2.2 mg/kg sc, iv, q 8 hr | For sepsis only, nephrotoxic, ototoxic |
| Tylosin | 10-20 mg/kg po q 12 hr | Aids in some cases of colitis/enteritis |
| Metronidazole | 7- 15 mg/kg po q 8- 12 hr | IBD, anaerobic bacteria, Giardia. Teratogenic and may be carcinogenic. |
| Immunosuppressive or anti-inflammatory drugs | ||
| Prednisolone | 0.5-3 mg/kg po q 12-48 hr depending upon condition | Taper higher doses over several months (e.g. 20% decrease q 2-3 weeks) |
| Ciclosporin | Dogs (older than 6 months): 5 mg/kg po q 12 -24 hr | Contraindicated or caution with drugs that inhibit cytochrome P450 enzymes, e.g. cimetidine. CI with hyperkalaemia Potential nephrotoxicity, especially if used with other potentially nephrotoxic drugs |
| Azathioprine | 2 mg/kg po q 24 hr until remission then 0.5-2 mg/kg po q 48 hr | Bone marrow suppression is the most serious potential adverse reaction, monitor haematology |
| Olsalazine | 10-20 mg/kg po q 12 hr | Local colonic NSAIDs. Less risk of KCS cf sulfasalazine |
| Sulfasalazine | Dogs: 15-30 mg/ kg po q 8-12 hr (max 6 g/day) Cats: 1-20 mg/kg po q 8-12 hr | Local NSAIDs. Risk of KCS |
| H2 receptor blockers (used to decrease gastric acidity) | ||
| Cimetidine | Dogs: 5-10 mg/kg iv, im, po q 8 hr Cats: 2.5-5.0 mg/ kg iv, im, po q 12 hr | Slows metabolism of other drugs by binding to hepatic microsomal cytochrome P450 and may increase their plasma concentrations. No known promotility effect |
| Ranitidine | 2 mg/kg sc, iv or slow iv 8-12 hr | Some prokinetic effect via muscarinic AchR |
| Famotidine | 0.5-1.0 mg/kg po q12-24 hr | Does not have the interaction of cimetidine, may or may not have prokinetic effects |
| Cytoprotective drugs | ||
| Sucralfate | Dogs: 500 mg/dog po q 6-8 hr for dogs up to 20 kg, 1-2 g/dog po q 6-8 hr for dogs >20 kg Cats: 250 mg/cat po q 8-12 hr | Aluminium ion binds to proteinaceous exudates forming a barrier over ulcerated areas. Promotes bicarbonate and prostaglandin E production which aids mucosal defense and repair. May decrease bioavailability of other drugs, especially tetracyclines |
| Misoprostol | Dogs: 2-7.5 pg/kg po q 8-12 hr Cats: 5 pg/kg po q 8 hr | Aids in protection of the GI ulcers due to NSAIDs. Side effects include diarrhoea, vomiting, abortion |
More on the topic Medications used in the treatment of gastrointestinal disorders:
- Medications used in the treatment of gastrointestinal disorders
- Macrovascular Complications of Diabetes Mellitus
- Agrawal M.. Textbook of Pediatrics. 3rd ed. — CBS Publishers,2025. — 973 p., 2025
- I OSTEOPOROSIS ^470 ^485 ^508 ^571
- 1 Primary and Preventive Care